StockNews.AI
SLQT
StockNews.AI
2 days

Shareholders who lost money in shares of SelectQuote, Inc. (NYSE: SLQT)Should Contact Wolf Haldenstein Immediately.

1. A class action lawsuit alleges misleading practices by SelectQuote. 2. Investors claim SelectQuote favored insurers paying the highest commissions. 3. DOJ filed complaints regarding illegal kickbacks accepted by SelectQuote. 4. Stock price fell 19.2% post-DOJ announcement on May 1, 2025. 5. Investors have until October 10, 2025, to join the lawsuit.

13m saved
Insight
Article

FAQ

Why Very Bearish?

The class action lawsuit and allegations from the DOJ indicate serious legal risks. Such situations have historically led to significant stock price declines, as seen after negative news affected other companies.

How important is it?

The lawsuit could significantly impact investor confidence and SLQT’s market performance. Given the severity of the allegations and the historical precedent of similar cases, the likelihood of a negative impact is high.

Why Short Term?

The immediate concerns of legal repercussions may weigh heavily on SLQT's stock price. Market reactions to such news are typically swift and pronounced in the short run.

Related Companies

CNCUNHAET

Lead Plaintiff Deadline is October 10, 2025

NEW YORK, Aug. 21, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired of SelectQuote, Inc. (NYSE:SLQT) ("SelectQuote or the "Company") securities between September 9, 2020 and May 1, 2025, inclusive (the "Class Period").

PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION

 Allegations

The filed complaint alleges that SelectQuote and its executives misled investors by failing to disclose that:

  1. The company steered Medicare beneficiaries to insurance plans from providers that paid SelectQuote the highest commissions, not necessarily those best suited for customers.
  2. SelectQuote did not provide unbiased Medicare Advantage comparisons as claimed.
  3. The company accepted illegal kickbacks to favor certain insurers and limit competition.
  4. SelectQuote was therefore not in compliance with laws, regulations, and contracts.
  5. This exposed the company to regulatory and legal risk, including under the False Claims Act (FCA).
  6. Positive statements about the company's business and prospects were misleading and lacked a reasonable basis.

Key Event

Impact on Investors

  • Following the DOJ announcement on May 1, 2025, SelectQuote's stock price fell 19.2%, dropping $0.61 to close at $2.56 per share.

Investors have until October 10, 2025 to seek appointment as lead plaintiff in the case.

Why Wolf Haldenstein Adler Freeman & Herz LLP?:

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

Contact:

Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholders-who-lost-money-in-shares-of-selectquote-inc-nyse-slqtshould-contact-wolf-haldenstein-immediately-302535193.html

SOURCE Wolf Haldenstein Adler Freeman & Herz LLP

Related News